| Jeevan Scientific Technology Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 538837 |
NSE Symbol : - |
P/E(TTM) : 129.44 |
|
ISIN Demat : INE237B01018 |
Div & Yield% : - |
EPS(TTM) : 0.39 |
|
Book Value(₹) : 32.37 |
Market Cap(₹Cr) : 79.93 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 10.30 | 12.52 | 9.92 | 10.13 | 8.06 | 10.39 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10.30 | 12.52 | 9.92 | 10.13 | 8.06 | 10.39 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.16 | 0.11 | 0.25 | -0.12 | 0.26 | 0.30 |
| Total Income | 10.46 | 12.63 | 10.17 | 10.01 | 8.32 | 10.68 |
| Total Expenditure | 8.36 | 9.13 | 9.37 | 9.04 | 7.39 | 8.34 |
| PBIDT | 2.11 | 3.50 | 0.80 | 0.98 | 0.93 | 2.34 |
| Interest | 0.27 | 0.15 | 0.16 | 0.13 | 0.25 | 0.19 |
| PBDT | 1.84 | 3.35 | 0.64 | 0.85 | 0.68 | 2.15 |
| Depreciation | 1.25 | 1.28 | 1.41 | 1.35 | 1.38 | 1.42 |
| Tax | 0.00 | 0.00 | 0.00 | -0.01 | 0.01 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.44 | 0.47 | -0.03 | -0.10 | -0.20 | 0.15 |
| Reported Profit After Tax | 0.15 | 1.60 | -0.74 | -0.39 | -0.50 | 0.58 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.15 | 1.60 | -0.74 | -0.39 | -0.50 | 0.58 |
| EPS (Unit Curr.) | 0.10 | 1.03 | -0.48 | -0.25 | -0.32 | 0.38 |
| EPS (Adj) (Unit Curr.) | 0.10 | 1.03 | -0.48 | -0.25 | -0.32 | 0.38 |
| Calculated EPS (Unit Curr.) | 0.10 | 1.03 | -0.48 | -0.25 | -0.32 | 0.38 |
| Calculated EPS (Adj) (Unit Curr.) | 0.10 | 1.03 | -0.48 | -0.25 | -0.32 | 0.38 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.39 | 4.14 | -1.90 | -1.02 | -1.30 | 1.51 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.39 | 4.14 | -1.90 | -1.02 | -1.30 | 1.51 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.48 | 15.48 | 15.48 | 15.48 | 15.48 | 15.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 20.49 | 27.96 | 8.06 | 9.67 | 11.54 | 22.52 |
| PBDTM(%) | 17.86 | 26.76 | 6.45 | 8.39 | 8.44 | 20.69 |
| PATM(%) | 1.46 | 12.78 | -7.46 | -3.85 | -6.20 | 5.58 |